There is a lot relying on the FDA approval, and I'd certainly think we would see a huge peak in the share price.
Ideally if there was a sales update / RNS at a similar time.
Everything is lined up here, and actually happening now - eg it's got to market. Bring on FDA and then get it to market in USA. Think there's a few more ups and downs along the way, but the sky is the limit at the moment.
Futura Medical plc
("Futura" or the "Company")
Board Appointment
Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain, is pleased to announce that Jeff Needham has been appointed to the Board as a non-executive director with immediate effect.
Jeff brings a wealth of knowledge and experience to the Board having been at Perrigo Company plc, the US-based manufacturer and marketer of consumer healthcare products, for 36 years, and a board director of the Consumer Healthcare Products Association for 12 years. Whilst at Perrigo, Jeff was responsible for the consumer self-care businesses in the Americas, that included Perrigo's US OTC Drug business, Nutritionals, Oral Care and its businesses in Mexico and Canada. Jeff's focus was on the development and long-term strategic direction of the business, including marketing, sales, new product pipeline development, business development and scientific affairs.
Commenting on the appointment, James Barder, Chief Executive Officer of the Company, said: "We are delighted to welcome Jeff, a seasoned and highly respected industry leader, to the Board of Directors. His unparalleled management, strategic and corporate expertise, especially in Consumer Health, OTC and the USA underscores our ambition and focus on building a global brand to deliver MED3000, our breakthrough treatment for erectile dysfunction to sufferers as a therapy option without the need for a doctor's prescription."
In accordance with Schedule 2(g) of the AIM Rules, Jeffrey Robert Needham (aged 65) holds or has held directorships of the following companies:
Agree, it’s definitely been a rollercoaster over the years.
And guess the hope is FUM have learnt from the past errors and engage some expert commercial knowledge.
A deal is critical, and going it alone doesn’t sound sensible.
But everything seems to be aligning in the right direction. They have something now, with EU CE Mark.
Let’s hope the next few weeks goes well.
It’s just so frustrating isn’t it?
Why not focus on a balanced view, give both sides of the debate backed with relevant and up to date information. Of course nothing is certain and road can be long.
Having followed this company for many years and recently invested over the past 2-3 years. This really does appear to now be in a positive position.
With a strong product, backed up through the regulatory bodies and then strong marketing and commercial vision, then a positive outcome should follow.
Good article to summarise current position. I guess the main word for investors is ‘patience’.
Having been up and down on this stock over the years. This time does feel different, and hopefully a steady climb now, just waiting on the next RNS, which is hopefully commercial news.
https://www.thearmchairtrader.com/futura-medical-share-price-forecast-26032021/
14 posts doesn’t mean tyro or alter ego. It just means I’ve not posted much ever.
I’m heavily invested in FUM. Followed it for years. And just about floating at the moment.
I’m interested in useful and educated thoughts and information. Shame majority of the noise on here is just that, noise.